Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Study Comparing Tazarotene Cream 0.05% to TAZORAC® (Tazarotene) Cream 0.05% and Both to a Placebo Control in the Treatment of Plaque Psoriasis

ClinicalTrials.gov ID: NCT02886702

Public ClinicalTrials.gov record NCT02886702. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 23, 2026, 12:14 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multi-Center, Double-Blind, Randomized, Vehicle-Controlled, Parallel-Group Study Comparing Tazarotene Cream 0.05% to TAZORAC® (Tazarotene) Cream 0.05% and Both Active Treatments to a Vehicle Control in the Treatment of Stable Plaque Psoriasis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

A Multi-Center, Double-Blind, Randomized, Vehicle-Controlled, Parallel-Group Study Comparing Tazarotene Cream 0.05% to TAZORAC® (tazarotene) Cream 0.05% and Both Active Treatments to a Vehicle Control in the Treatment of Stable Plaque Psoriasis

Study identification

NCT ID
NCT02886702
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Fougera Pharmaceuticals Inc.
Industry
Enrollment
855 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 19, 2016 (Actual)
Primary completion
Aug 2, 2017 (Actual)
Completion
Aug 2, 2017 (Actual)
Last update posted
Aug 29, 2018

2016 – 2017

United States locations

U.S. sites
30
U.S. states
15
U.S. cities
28
Facility City State ZIP Site status
Fougera Investigational Site Phoenix Arizona 85018 —
Fougera Investigational Site Hot Springs Arkansas 71913 —
Fougera Investigational Site Anaheim California 92801 —
Fougera Investigational Site North Hollywood California 91606 —
Fougera Investigational Site San Diego California 92108 —
Fougera Investigational Site San Ramon California 94582 —
Fougera Investigational Site Brandon Florida 33511 —
Fougera Investigational Site Coral Gables Florida 33134 —
Fougera Investigational Site Hialeah Florida 33016 —
Fougera Investigational Site Miami Florida 33015 —
Fougera Investigational Site Miami Florida 33143 —
Fougera Investigational Site Miami Florida 33175 —
Fougera Investigational Site Miami Gardens Florida 33169 —
Fougera Investigational Site Miramar Florida 33027 —
Fougera Investigational Site Sweetwater Florida 33172 —
Fougera Investigational Site Tampa Florida 33618 —
Fougera Investigational Site West Palm Beach Florida 33406 —
Fougera Investigational Site Macon Georgia 31217 —
Fougera Investigational Site Arlington Heights Illinois 60005 —
Fougera Investigational Site New Albany Indiana 47150 —
Fougera Investigational Site Plainfield Indiana 46168 —
Fougera Investigational Site Louisville Kentucky 40202 —
Fougera Investigational Site Lake Charles Louisiana 70605 —
Fougera Investigational Site Saint Joseph Missouri 91606 —
Fougera Investigational Site Henderson Nevada 89052 —
Fougera Investigational Site High Point North Carolina 27262 —
Fougera Investigational Site Salem Oregon 97302 —
Fougera Investigational Site Hazleton Pennsylvania 18201 —
Fougera Investigational Site Upper Saint Clair Pennsylvania 15241 —
Fougera Investigational Site San Antonio Texas 78207 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02886702, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 29, 2018 · Synced Oct 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02886702 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →